ロード中...
Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells
The aims of this study were to determine whether combination chemotherapeutics exhibit a synergistic effect on breast cancer cell metabolism. Palbociclib, is a selective inhibitor of cyclin-dependent kinases 4 and 6, and when patients are treated in combination with fulvestrant, an estrogen receptor...
保存先:
| 出版年: | Metabolites |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359333/ https://ncbi.nlm.nih.gov/pubmed/30609717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo9010007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|